These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28935269)

  • 1. Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior.
    Parellada M; Llorente C; Calvo R; Gutierrez S; Lázaro L; Graell M; Guisasola M; Dorado ML; Boada L; Romo J; Dulin E; Sanz I; Arango C; Moreno C
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1319-1330. PubMed ID: 28935269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore.
    Ooi YP; Weng SJ; Jang LY; Low L; Seah J; Teo S; Ang RP; Lim CG; Liew A; Fung DS; Sung M
    Eur J Clin Nutr; 2015 Aug; 69(8):969-71. PubMed ID: 25804268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ω6/ω3 Polyunsaturated fatty acid supplementations in renal cell model lead to a particular regulation through lipidome for preserved ω6/ω3 ratios.
    Fares M; Armand M; Francois C; Maixent JM
    Cell Mol Biol (Noisy-le-grand); 2012 Jun; 58 Suppl():OL1715-9. PubMed ID: 22762527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation (IL-1β) Modifies the Effect of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids on Core Symptoms of Autism Spectrum Disorder-An Exploratory Pilot Study
    Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; von Hurst PR
    Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children.
    Saad K; Abdel-Rahman AA; Elserogy YM; Al-Atram AA; Cannell JJ; Bjørklund G; Abdel-Reheim MK; Othman HA; El-Houfey AA; Abd El-Aziz NH; Abd El-Baseer KA; Ahmed AE; Ali AM
    Nutr Neurosci; 2016 Oct; 19(8):346-351. PubMed ID: 25876214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial.
    Mazahery H; Conlon C; Beck KL; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; Mugridge O; von Hurst PR
    Trials; 2016 Jun; 17(1):295. PubMed ID: 27334138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder.
    Keim SA; Jude A; Smith K; Khan AQ; Coury DL; Rausch J; Udaipuria S; Norris M; Bartram LR; Narayanan AR; Rogers LK
    J Autism Dev Disord; 2022 Dec; 52(12):5342-5355. PubMed ID: 35013866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder.
    Mazahery H; Conlon CA; Beck KL; Mugridge O; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Jones B; von Hurst PR
    J Steroid Biochem Mol Biol; 2019 Mar; 187():9-16. PubMed ID: 30744880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women.
    Wang L; Manson JE; Rautiainen S; Gaziano JM; Buring JE; Tsai MY; Sesso HD
    Eur J Nutr; 2016 Mar; 55(2):687-697. PubMed ID: 25820817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ω-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis.
    Horvath A; Łukasik J; Szajewska H
    J Nutr; 2017 Mar; 147(3):367-376. PubMed ID: 28077731
    [No Abstract]   [Full Text] [Related]  

  • 11. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.
    Amminger GP; Berger GE; Schäfer MR; Klier C; Friedrich MH; Feucht M
    Biol Psychiatry; 2007 Feb; 61(4):551-3. PubMed ID: 16920077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in the fatty acid pattern of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with gastrointestinal diseases.
    Siener R; Alteheld B; Terjung B; Junghans B; Bitterlich N; Stehle P; Metzner C
    Eur J Clin Nutr; 2010 Apr; 64(4):410-8. PubMed ID: 20160750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of omega-3 fatty acids supplementation on social and behavioral disorders of children with autism: a randomized clinical trial.
    Doaei S; Bourbour F; Teymoori Z; Jafari F; Kalantari N; Abbas Torki S; Ashoori N; Nemat Gorgani S; Gholamalizadeh M
    Pediatr Endocrinol Diabetes Metab; 2021; 27(1):12-18. PubMed ID: 33599431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
    Eriksdotter M; Vedin I; Falahati F; Freund-Levi Y; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Cederholm T; Palmblad J
    J Alzheimers Dis; 2015; 48(3):805-12. PubMed ID: 26402079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Omega-3-6-9 fatty acid supplementation on behavior and sleep in preterm toddlers with autism symptomatology: Secondary analysis of a randomized clinical trial.
    Boone KM; Klebanoff MA; Rogers LK; Rausch J; Coury DL; Keim SA
    Early Hum Dev; 2022 Jun; 169():105588. PubMed ID: 35644107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Profile, Lipoprotein Subfractions, and Fluidity of Membranes in Children and Adolescents with Depressive Disorder: Effect of Omega-3 Fatty Acids in a Double-Blind Randomized Controlled Study.
    Katrenčíková B; Vaváková M; Waczulíková I; Oravec S; Garaiova I; Nagyová Z; Hlaváčová N; Ďuračková Z; Trebatická J
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis.
    Fraguas D; Díaz-Caneja CM; Pina-Camacho L; Moreno C; Durán-Cutilla M; Ayora M; González-Vioque E; de Matteis M; Hendren RL; Arango C; Parellada M
    Pediatrics; 2019 Nov; 144(5):. PubMed ID: 31586029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders.
    Yui K; Imataka G; Kawasak Y; Yamada H
    Life Sci; 2016 Jan; 145():205-12. PubMed ID: 26724495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
    Amminger GP; Schäfer MR; Papageorgiou K; Klier CM; Cotton SM; Harrigan SM; Mackinnon A; McGorry PD; Berger GE
    Arch Gen Psychiatry; 2010 Feb; 67(2):146-54. PubMed ID: 20124114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism.
    Mankad D; Dupuis A; Smile S; Roberts W; Brian J; Lui T; Genore L; Zaghloul D; Iaboni A; Marcon PM; Anagnostou E
    Mol Autism; 2015; 6():18. PubMed ID: 25798215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.